ATE226014T1 - Prophylaktische behandlung der allergischen kontaktdermatitis - Google Patents

Prophylaktische behandlung der allergischen kontaktdermatitis

Info

Publication number
ATE226014T1
ATE226014T1 AT95940002T AT95940002T ATE226014T1 AT E226014 T1 ATE226014 T1 AT E226014T1 AT 95940002 T AT95940002 T AT 95940002T AT 95940002 T AT95940002 T AT 95940002T AT E226014 T1 ATE226014 T1 AT E226014T1
Authority
AT
Austria
Prior art keywords
prophylactic treatment
contact dermatitis
allergic contact
skin
allergic
Prior art date
Application number
AT95940002T
Other languages
English (en)
Inventor
John J Wille
Agis Kydonieus
Frank S Castellana
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE226014T1 publication Critical patent/ATE226014T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT95940002T 1994-11-22 1995-11-15 Prophylaktische behandlung der allergischen kontaktdermatitis ATE226014T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/343,157 US5618557A (en) 1994-11-22 1994-11-22 Prophylactic treatment of allergic contact dermatitis
PCT/US1995/014918 WO1996015669A1 (en) 1994-11-22 1995-11-15 Prophylactic treatment of allergic contact dermatitis

Publications (1)

Publication Number Publication Date
ATE226014T1 true ATE226014T1 (de) 2002-11-15

Family

ID=23344937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95940002T ATE226014T1 (de) 1994-11-22 1995-11-15 Prophylaktische behandlung der allergischen kontaktdermatitis

Country Status (10)

Country Link
US (1) US5618557A (de)
EP (1) EP0802731B1 (de)
JP (1) JPH10512850A (de)
AT (1) ATE226014T1 (de)
AU (1) AU695804B2 (de)
CA (1) CA2205920A1 (de)
DE (1) DE69528602T2 (de)
MX (1) MX9703693A (de)
NZ (1) NZ296892A (de)
WO (1) WO1996015669A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
WO2007084464A2 (en) * 2006-01-17 2007-07-26 The University Of North Carolina At Chapel Hill Water channel blockers and methods of use thereof
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
PE20151054A1 (es) 2012-12-17 2015-08-07 Parion Sciences Inc Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales
MX2015007797A (es) 2012-12-17 2015-10-05 Parion Sciences Inc Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
EP3267875A4 (de) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Eingabe- und unterstützungssystem für heftiges verlangen
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968245A (en) * 1973-10-12 1976-07-06 Alza Corporation Sympathomimetic topical and percutaneous administration with halogenated promoters
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
WO1990009792A1 (en) * 1989-03-03 1990-09-07 The General Hospital Corporation Topical application of amiloride or analogues thereof for treatment of inflammation
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs

Also Published As

Publication number Publication date
US5618557A (en) 1997-04-08
AU4162896A (en) 1996-06-17
DE69528602T2 (de) 2003-06-26
NZ296892A (en) 1998-04-27
WO1996015669A1 (en) 1996-05-30
EP0802731B1 (de) 2002-10-16
EP0802731A1 (de) 1997-10-29
AU695804B2 (en) 1998-08-20
EP0802731A4 (de) 1999-08-04
CA2205920A1 (en) 1996-05-30
MX9703693A (es) 1998-02-28
DE69528602D1 (de) 2002-11-21
JPH10512850A (ja) 1998-12-08

Similar Documents

Publication Publication Date Title
DE69528602D1 (de) Prophylaktische behandlung der allergischen kontaktdermatitis
DE69529577D1 (de) Prophylaktische und therapeutische behandlung von haupt sensibilisierung und -reizung
PT880350E (pt) Tratamento de esclerose multipla
NO981392D0 (no) Substituerte pyrazolylbenzensulfonamider for anvendelse i veterinærterapi som antiinflammatorisk middel
ATE147258T1 (de) Haarnachbehandlungsmittel
ATE59547T1 (de) Mittel zum reduzieren der ausbreitung des sebums.
DE69021214D1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
NZ333324A (en) Prophylactic treatment of skin sensitization and irritation
DE69109292D1 (de) Verminderung oder verhütung der von arzneimitteln verursachten hautreizung.
DK261490D0 (da) New pharmaceutical compound
ATE185271T1 (de) Behandlung von durch talgdrüse verursachten erkrankungen mit inhibitoren der acyl coa cholesterin acyltransferase
ATE67662T1 (de) Topische antibiotische zusammensetzung zur behandlung der schleimhaeute.
ATE40946T1 (de) Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.
ATE335501T1 (de) Mittel zur behandlung von allergischen oder überempfindlichkeitszuständen
JPS5218813A (en) Plasters for the relief of cutaneous diseases
DE69333413D1 (de) 5-ht2-antagonisten in der behandlung venöser zustände
AU4726797A (en) Prophylactic/remedial agent
ATE130515T1 (de) Mittel zur topischen verabreichung von spironolakton.
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
NO984245L (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
NO941097D0 (no) Hudregenererende kosmetisk preparat
DE69531044D1 (de) Behandlung von entzündung durch die gabe von spezifischen sulfatase-enzymen und/oder inhibitoren der sulfatierung
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties